These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Frequency of IgA antibodies in pemphigus, bullous pemphigoid and mucous membrane pemphigoid. Cozzani E; Drosera M; Parodi A; Carrozzo M; Gandolfo S; Rebora A Acta Derm Venereol; 2004; 84(5):381-4. PubMed ID: 15370705 [TBL] [Abstract][Full Text] [Related]
66. [Benign pemphigoid of the mucous membranes: the clinical and histopathological aspects in 20 patients]. Capecchi M; Ficarra G; Pagni L Minerva Stomatol; 1994 Sep; 43(9):423-8. PubMed ID: 7816017 [TBL] [Abstract][Full Text] [Related]
67. Figurate erythema in a patient with bullous pemphigoid and Toxocara infection. Dolenc-Voljč M; Žgavec B; Vizjak A; Tenyi V; Luzar B Acta Dermatovenerol Alp Pannonica Adriat; 2013 Dec; 22(4):87-9. PubMed ID: 24336945 [TBL] [Abstract][Full Text] [Related]
68. New and emerging therapies for diseases of the oral cavity. Popovsky JL; Camisa C Dermatol Clin; 2000 Jan; 18(1):113-25. PubMed ID: 10626117 [TBL] [Abstract][Full Text] [Related]
69. Bullous pemphigoid with laryngeal involvement requiring emergency tracheostomy. Iinuma S; Hayashi K; Sato R; Ishida-Yamamoto A Int J Dermatol; 2022 Sep; 61(9):e338-e339. PubMed ID: 34859888 [No Abstract] [Full Text] [Related]
70. Topical tacrolimus treatment for cicatricial pemphigoid. Günther C; Wozel G; Meurer M; Pfeiffer C J Am Acad Dermatol; 2004 Feb; 50(2):325-6. PubMed ID: 14726899 [No Abstract] [Full Text] [Related]
71. Low-dose cyclosporine A in the treatment of disabling morphea. Peter RU; Ruzicka T; Eckert F Arch Dermatol; 1991 Sep; 127(9):1420-1. PubMed ID: 1892419 [No Abstract] [Full Text] [Related]
72. Bullous pemphigoid showing unusual ocular changes. Kiyokawa C; Fujito S; Mori O; Mochizuki M; Hashimoto T Br J Dermatol; 1998 Oct; 139(4):693-6. PubMed ID: 9892916 [TBL] [Abstract][Full Text] [Related]
75. Custom dental trays with topical corticosteroids for management of gingival lesions of mucous membrane pemphigoid. Kulkarni R; Payne AS; Werth VP; Sollecito TP; Stoopler ET Int J Dermatol; 2020 Jun; 59(6):e211-e213. PubMed ID: 31909487 [No Abstract] [Full Text] [Related]
76. Oral and topical corticosteroids in bullous pemphigoid. Spigel GT N Engl J Med; 2002 Jul; 347(2):143-5; author reply 143-5. PubMed ID: 12117002 [No Abstract] [Full Text] [Related]
77. A severe case of IgA bullous pemphigoid successfully treated with dupilumab. Valenti M; De Giacomo P; Lavecchia A; Valenti G Dermatol Ther; 2022 Nov; 35(11):e15890. PubMed ID: 36181411 [No Abstract] [Full Text] [Related]
78. Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid. Chu J; Bradley M; Marinkovich MP Arch Dermatol; 2003 Jun; 139(6):813-5. PubMed ID: 12810523 [No Abstract] [Full Text] [Related]
79. [Bullous diseases of the pemphigus group]. Portugal C; Rodrigues M; de Campos C Rev Port Estomatol Cir Maxilofac; 1982; 23(4):471-81. PubMed ID: 7188101 [No Abstract] [Full Text] [Related]
80. Benign mucous membrane pemphigoid: immunopathological study of three cases. Fabbri P; Fattorossi A; Panconesi E Ital Gen Rev Dermatol; 1978; 15(1):17-24. PubMed ID: 399954 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]